Reynolds Tobacco Company Wins U.S. Supreme Court Support to Challenge FDA Ruling Locally

Jun.23.2025
Reynolds Tobacco Company Wins U.S. Supreme Court Support to Challenge FDA Ruling Locally
On June 20, the U.S. Supreme Court ruled 7-2 in favor of e-cigarette companies, making it easier for them to sue over FDA decisions blocking product market entry. The case, filed by RJ Reynolds, challenges FDA’s denial of the Vuse Alto e-cigarette. The ruling could shift the balance between the industry and regulators.

Key Points:

 

·Court ruling: In a 7-2 decision, the Supreme Court supports e-cigarette companies, loosening litigation restrictions and allowing more businesses to challenge FDA bans. 

 

·Case background: Reynolds e-cigarette company (RJ Reynolds) filed a lawsuit against the FDA for refusing to authorize its Vuse Alto e-cigarette. 

 

·The company partnered with retailers in Texas, a conservative majority state, to file the lawsuit in the Fifth Circuit Court of Appeals. 

 

·Legal impact: Retailers and distributors affected by FDA decisions can now file lawsuits in local courts, not just manufacturers. 

 

·This may increase e-cigarette companies' chances of choosing favorable courts. 

 

·Judicial division: Majority opinion (Justice Barrett): Believes the law allows affected businesses (like retailers) to file lawsuits. 

 

·Dissenting opinion (Justices Jackson and Sotomayor): Warns that the ruling could undermine regulatory consistency and promote evasion behavior. 

 

·Industry and regulatory conflict: FDA has recently strengthened control over flavored e-cigarettes, but the industry continues to push back through legal means. 

 

·This ruling may weaken FDA's regulatory efforts and impact the future landscape of the e-cigarette market.

 

·The ruling marks a key victory for the e-cigarette industry in its fight against federal regulations, potentially leading to more similar lawsuits and further affecting e-cigarette policies in the US.

 


 

According to a report from the Associated Press on June 20th, the Supreme Court of the United States voted 7-2 in favor of Reynolds Vapor Co., a subsidiary of Reynolds Tobacco, allowing them to challenge the FDA's decision to refuse their e-cigarette marketing application in the Fifth Circuit Court of Appeals.

 

At the time of this ruling, major e-cigarette companies are opposing the federal government's years-long crackdown on e-cigarettes. It is expected that the ruling will give e-cigarette companies more autonomy to decide which judges will preside over lawsuits against e-cigarette entities.

 

In a ruling in April, judges reversed their stance on e-cigarettes, supporting the FDA's decision to maintain a comprehensive ban on most flavored e-cigarettes following a surge in youth vaping.

 

The current case is brought by the Reynolds e-cigarette company, which had already sold a range of popular berry and mint-flavored e-cigarette products before the FDA began regulating the market in accordance with the Tobacco Control Act in 2016.

 

The FDA has rejected approval of the company's Vuse Alto product. Supreme Court Justice Amy Coney Barrett wrote in the majority opinion that this decision "rings the death knell for a significant portion of the e-cigarette market.

 

The company is headquartered in North Carolina, where it is typically only able to challenge the FDA in local courts or in the FDA's headquarters in Washington D.C. However, the company has teamed up with a Texas-based business that sells its products to file a lawsuit locally. The conservative U.S. Fifth Circuit Court of Appeals has allowed the lawsuit to proceed, ruling that any business that suffers harm to its operations due to an FDA decision can file a lawsuit.

 

The FDA has filed an appeal to the Supreme Court, alleging that the e-cigarette company Reynolds is attempting to find a favorable court for its arguments.

 

However, judges found that the law does allow other businesses, such as e-cigarette retailers, affected by FDA decisions to file lawsuits in their state.

 

Supreme Court Justices Ketanji Brown Jackson and Sonia Sotomayor, who hold differing opinions, both agree that they will stand by the institution.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA’s launch of a web-based PMTA system signals faster reviews and, 2Firsts experts say, a possible inflection point for the U.S. e-cigarette market’s shift out of the grey zone.
Dec.04
The Spark of Reason| 2Firsts 2026 New Year Message
The Spark of Reason| 2Firsts 2026 New Year Message
Looking ahead to 2026, we do so with genuine anticipation. This will be a milestone year—the dawn of a new era.
Jan.01
South Korea’s National Assembly Passes Law Classifying E-Cigarettes as Tobacco Products with Full Equivalent Regulation
South Korea’s National Assembly Passes Law Classifying E-Cigarettes as Tobacco Products with Full Equivalent Regulation
South Korea’s National Assembly recently passed a comprehensive package of 79 bills that, among other measures, formally classifies liquid vapes — e-cigarette products using nicotine-containing e-liquids — as tobacco products. These products will now be subject to the same taxation, sales restrictions and advertising controls as traditional cigarettes, and the vaping industry in South Korea is expected to face significant adjustments in compliance costs, market access and business strategy.
Dec.03
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
A bill endorsing a licensing system for tobacco and nicotine products has been recommended in Russia's State Duma.
Nov.14 by 2FIRSTS.ai
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai